Kuga Yoshio, Tanaka Tomotaka, Arita Michinori, Usui Yoshiki, Okanobu Hideharu, Numata Yoshihiro, Miwata Tomohiro, Yoshimi Satoshi, Murakami Eisuke, Moriya Takashi, Ohya Toshihide, Nishida Toshihiro
Dept. of Internal Medicine, Chugoku Rosai Hospital.
Gan To Kagaku Ryoho. 2009 Nov;36(11):1923-5.
We report a case of left inguinal lymph node metastasis of anal canal carcinoma, treated effectively with chemotherapy consisting of S-1 and CDDP combined with radiotherapy. In February 2006, a 76-year-old woman underwent resection of a tumor diagnosed as squamous cell carcinoma of the anal canal. The patient refused additional surgical therapy. In August 2007, a painful lymphnode swelling was noticed in the left inguinal region. Biopsy was performed, and specimens were shown to include squamous cell carcinoma cells. The patient was treated using chemotherapy concurrent with radiotherapy. The chemotherapy consisted of oral S-1 (80 mg/body/day; 5 days/week) and intravenous CDDP (5 mg/body/day; 5 days/week), both administered for 4 weeks. Radiotherapy at 2 Gy/day was administered 25 times (total dose 50 Gy). The metastatic tumor in the lymph node responded well to the treatment and decreased remarkably in size by December 2007. After chemoradiotherapy, the oral administration of S-1 alone (80 mg/body) for 2 weeks followed by a 2-week rest period as one course was continued for 1 year. The lymph node metastasis had disappeared 1 year after chemoradiotherapy, as determined by computed tomography (CT) and positron emission tomography-CT, representing a complete response. Chemotherapy consisting of S-1 and CDDP concurrent with radiotherapy maybe effective for treating metastatic lymph node metastasis of anal canal carcinoma.
我们报告一例肛管癌左腹股沟淋巴结转移患者,采用S-1和顺铂联合放疗的化疗方案治疗有效。2006年2月,一名76岁女性接受了肿瘤切除术,该肿瘤被诊断为肛管鳞状细胞癌。患者拒绝进一步手术治疗。2007年8月,左侧腹股沟区出现疼痛性淋巴结肿大。进行了活检,标本显示含有鳞状癌细胞。患者接受了化疗同步放疗。化疗方案为口服S-1(80mg/体/天;每周5天)和静脉注射顺铂(5mg/体/天;每周5天),均持续4周。放疗剂量为每天2Gy,共进行25次(总剂量50Gy)。淋巴结中的转移瘤对治疗反应良好,到2007年12月时大小显著减小。放化疗后,单独口服S-1(80mg/体)2周,随后休息2周为一个疗程,持续进行1年。放化疗1年后,经计算机断层扫描(CT)和正电子发射断层扫描-CT检查确定,淋巴结转移已消失,达到完全缓解。由S-1和顺铂组成的化疗同步放疗可能对治疗肛管癌转移性淋巴结转移有效。